Coegin Pharma AB
🇸🇪Sweden
- Country
- 🇸🇪Sweden
- Ownership
- Public
- Established
- 2005-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.coeginpharma.com
Phase I/IIa Trial to Evaluate AVX001 Gel in Doses of 1% or 3% Compared With Vehicle Over Four Weeks of Field-directed Treatment Period in Adult Subjects With AK
- First Posted Date
- 2021-12-20
- Last Posted Date
- 2022-01-27
- Lead Sponsor
- Coegin Pharma AB
- Target Recruit Count
- 60
- Registration Number
- NCT05164393
- Locations
- 🇩🇰
Bispebjerg Hospital, Copenhagen, Zealand, Denmark
© Copyright 2025. All Rights Reserved by MedPath